GlassScriptPhysician profile
Vanessa Obas
NPI 1801258645
$5,854.91
in general payments reported to CMS, 2019-2025
15 companies · $1,803 in 2025
The $1,803 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,366 · 2023: $1,686 · 2025: $1,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058 · Travel and Lodging: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.99 |
| Travel and Lodging | $1,430.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,720.23 | 2022-2023 | |
| Philips North America LLC | $1,610.13 | 2025 | Igt Devices Undivided |
| Abbott Laboratories | $1,142.53 | 2022-2025 | Optis, Xience Skypoint, Diamondback Coronary |
| Medtronic, INC. | $368.67 | 2022-2023 | Telescope, Onyx Frontier, Spiderfx |
| Shockwave Medical, INC | $198.28 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $148.00 | 2022 | |
| Edwards Lifesciences Corporation | $123.23 | 2022 | |
| Cathworks, INC. | $110.85 | 2023 | Ffrangio |
| Cordis US Corp. | $102.06 | 2023 | Mynx Control |
| Ge Healthcare | $100.21 | 2022 | |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Cook Medical LLC | $48.78 | 2023 | Zenith Alpha |
| Amgen INC. | $46.85 | 2023 | Repatha |
| Terumo Medical Corporation | $46.44 | 2022 | |
| Abiomed | $25.59 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Obas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.